ArticleBritish journal of cancer2012

Smaller sample sizes for phase II trials based on exact tests with actual error rates by trading-off their nominal levels of significance and power.

I Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.